PMID: 1054489Jan 1, 1975Paper

Mitogenic activity of blood components. I. Thrombin and prothrombin

Proceedings of the National Academy of Sciences of the United States of America
L B Chen, J M Buchanan

Abstract

When added to a culture medium of resting confluent chick embryo fibroblasts in the absence of serum, thrombin (EC 3.4.21.5) is able to stimulate DNA synthesis 12 hr later and to cause a substantial increase in cell number over a period of 4 days. As compared to thrombin, prothrombin exhibits low mitogenic activity. However, in the presence of purified Factor Xa (EC 3.4.21.6) and Factor V, prothrombin is converted to thrombin by "thromboplastin activity" supplied by the fibroblasts. Prothrombin, either purified or as a constituent of plasma or serum, may thus be considered to be a reservoir of mitogenic activity in tissue culture unless antithrombin is present in the culture medium in amounts sufficient to neutralize the thrombin formed. By use of a specific inhibitor of proteases, and by separation of prothrombin by absorption on BaSO4, we estimate that the potential mitogenic activity of prothrombin is approximately 30-50% of the total activity that can be obtained by treatment of fibrinogen-free plasma with thromboplastin. In addition to its mitogenic activity, thrombin can also stimulate the migration of cells. These experiments with thrombin illustrate that well-characterized proteases of blood can act as potent mitogens a...Continue Reading

References

Mar 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·S D BalkA C Braun
Feb 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·R R Bürk
Jul 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·R W Hollwy, J A Kiernan
May 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·R W Holley, J A Kiernan

❮ Previous
Next ❯

Citations

Jan 1, 1996·Journal of Cellular Physiology·M T ArmstrongP B Armstrong
May 6, 1999·Journal of Cellular Physiology·C MbebiM Verdière-Sahuqué
Sep 1, 1990·Journal of Cellular Physiology·C M Oliveira, D K Banerjee
Jan 1, 1978·Journal of Supramolecular Structure·D H Carney, D D Cunningham
Jan 1, 1979·Journal of Supramolecular Structure·D D CunninghamD A Low
Jan 1, 1979·Journal of Supramolecular Structure·B R Zetter, H N Antoniades
Jan 1, 1983·Cancer Metastasis Reviews·H F DvorakA M Dvorak
Feb 23, 1979·Archives of Dermatological Research·K S Stenn, I Dvoretzky
Jan 1, 1990·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·D G PuroH Shimada
Feb 2, 1981·Klinische Wochenschrift·H D Bruhn, J Pohl
Jan 1, 1988·Neurosurgical Review·T Herter
Aug 21, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Sven DanckwardtAndreas E Kulozik
Jul 20, 2007·Cell and Tissue Research·Lisa R AmirAntonius L J J Bronckers
Mar 15, 1990·Biochemical Pharmacology·K Seuwen, J Pouysségur
Apr 11, 1994·European Journal of Pharmacology·M J Antonaccio, D Normandin
Oct 1, 1988·Journal of Biological Standardization·J VaraniW J Hillegas
Jan 1, 1987·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·G K Scott
Dec 1, 1992·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·G K Scott
Jan 1, 1987·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·F PerraudG Labourdette
Jan 1, 1988·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·F PerraudM Sensenbrenner
Mar 1, 1994·Trends in Cardiovascular Medicine·S R Coughlin
Jul 22, 1998·European Journal of Pharmacology·M S ChintalaE J Sybertz
Nov 5, 1997·Progress in Cardiovascular Diseases·J Lefkovits, E J Topol
Sep 7, 2000·Thrombosis Research·M R Buchanan, S J Brister
Jun 14, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·James W Denham, Martin Hauer-Jensen
Apr 3, 1998·Journal of Lipid Mediators and Cell Signalling·C M MalliaB S Beckman
Nov 26, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takayuki IseToshio Matsumoto
Jan 9, 2009·Mucosal Immunology·M S Wilson, T A Wynn
Jan 4, 2012·Nature Reviews. Drug Discovery·Rithwik RamachandranMorley D Hollenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.